SAM
AKCA

Shell Asset Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Shell Asset Management’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,343
Closed -$133K – 1484
2020
Q3 		$133K Hold
7,343
– – ﹤0.01% 1126
2020
Q2 		$101K Buy
+7,343
New +$113K ﹤0.01% 1147

Shell Asset Management's AKCA Position: Q4 2020 in Review

Shell Asset Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 7,343 shares — an estimated $133K sold.

Shell Asset Management first reported a position in AKCA in Q2 2020 and held it in 2 quarters. The position peaked at $133K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Shell Asset Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Shell Asset Management sold 7,343 Akcea Therapeutics Inc shares in Q4 2020, an estimated $133K.
  • Shell Asset Management first reported a position in Akcea Therapeutics Inc in Q2 2020 and held it in 2 quarters.
  • Shell Asset Management's Akcea Therapeutics Inc position peaked at $133K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Shell Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.